stella
beta
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus — Stella
Recruiting
Back to Systemic Lupus Erythematosus trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov